The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping technology, today announced the presentation of data ...

Despite setbacks and funding cuts — and a quieting of the hype blaring its arrival — multiple CRISPR-based trials are ...

Maya Ajmera, President & CEO of the Society for Science and Executive Publisher of Science News, spoke with David R. Liu, Thomas Dudley Cabot Professor of ...

Key market opportunities in mutation detection kits for genome editing include addressing rising genetic disorders with ...

This interesting study adapts machine learning tools to analyze movements of a chromatin locus in living cells in response to serum starvation. The machine learning approach developed is useful, the ...

A research team at Lund University in Sweden has discovered a mechanism that helps acute myeloid leukemia cells to evade the ...

High-rolling investors have positioned themselves bearish on CRISPR Therapeutics (NASDAQ:CRSP), and it's important for retail traders to take note. \This activity came to our attention today through ...

Hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) is a rare, multisystem, progressive, debilitating, and fatal disease characterized by tissue deposition of misfolded transthyretin ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing "copilot" ...

Development of bespoke therapies has been a driving goal in medical research. This year, the announcement of the first patient treated with personalized CRISPR therapy, Baby KJ, highlights this ...